Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Related Research Data
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.
Source:
American Association for Cancer Research (AACR)
Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
Source:
Cold Spring Harbor Laboratory
Fibroblast growth factor signalling: from development to cancer
Source:
Springer Science and Business Media LLC
Toxicity of targeted therapy in non-small-cell lung cancer management.
Source:
Elsevier BV
Synthesis and evaluation of biological and antitumor activities of 5,7-dimethyl- oxazolo[5,4-d]pyrimidine-4,6(5H,7H)-dione derivatives as novel inhibitors of FGFR1.
Source:
Informa UK Limited
De-regulated FGF receptors as therapeutic targets in cancer.
Source:
Elsevier BV
Targeting FGFR Signaling in Cancer
Source:
American Association for Cancer Research (AACR)
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Source:
Informa Healthcare
PyMine: a PyMOL plugin to integrate and visualize data for drug discovery
Source:
Springer Science and Business Media LLC
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
Source:
American Chemical Society (ACS)
A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis
Source:
Springer Science and Business Media LLC
Discovery of [5-Amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone (CH5183284/Debio 1347), An Orally Available and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor.
Source:
American Chemical Society (ACS)
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications
Source:
eScholarship, University of California
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling.
Source:
Elsevier Inc.
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Source:
American Association for Cancer Research (AACR)
Protein–Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR Tyrosine Kinase
Source:
American Chemical Society (ACS)
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.
Source:
Springer Science and Business Media LLC
Linking provided by
